S&P 500   4,228.67 (-1.39%)
DOW   33,016.71 (-1.25%)
QQQ   355.08 (-1.71%)
AAPL   172.09 (-0.96%)
MSFT   312.84 (-2.78%)
META   300.00 (-2.22%)
GOOGL   132.92 (-0.93%)
AMZN   125.16 (-3.32%)
TSLA   248.04 (-1.41%)
NVDA   436.22 (-2.59%)
NIO   8.70 (-1.02%)
BABA   84.61 (-2.22%)
AMD   100.33 (-2.85%)
T   14.68 (+0.07%)
F   12.07 (-1.95%)
MU   68.16 (+0.29%)
CGC   0.70 (-5.10%)
GE   107.58 (-1.11%)
DIS   80.05 (-1.98%)
AMC   8.08 (-0.86%)
PFE   34.10 (+0.47%)
PYPL   57.66 (-1.54%)
NFLX   376.18 (-1.09%)
S&P 500   4,228.67 (-1.39%)
DOW   33,016.71 (-1.25%)
QQQ   355.08 (-1.71%)
AAPL   172.09 (-0.96%)
MSFT   312.84 (-2.78%)
META   300.00 (-2.22%)
GOOGL   132.92 (-0.93%)
AMZN   125.16 (-3.32%)
TSLA   248.04 (-1.41%)
NVDA   436.22 (-2.59%)
NIO   8.70 (-1.02%)
BABA   84.61 (-2.22%)
AMD   100.33 (-2.85%)
T   14.68 (+0.07%)
F   12.07 (-1.95%)
MU   68.16 (+0.29%)
CGC   0.70 (-5.10%)
GE   107.58 (-1.11%)
DIS   80.05 (-1.98%)
AMC   8.08 (-0.86%)
PFE   34.10 (+0.47%)
PYPL   57.66 (-1.54%)
NFLX   376.18 (-1.09%)
S&P 500   4,228.67 (-1.39%)
DOW   33,016.71 (-1.25%)
QQQ   355.08 (-1.71%)
AAPL   172.09 (-0.96%)
MSFT   312.84 (-2.78%)
META   300.00 (-2.22%)
GOOGL   132.92 (-0.93%)
AMZN   125.16 (-3.32%)
TSLA   248.04 (-1.41%)
NVDA   436.22 (-2.59%)
NIO   8.70 (-1.02%)
BABA   84.61 (-2.22%)
AMD   100.33 (-2.85%)
T   14.68 (+0.07%)
F   12.07 (-1.95%)
MU   68.16 (+0.29%)
CGC   0.70 (-5.10%)
GE   107.58 (-1.11%)
DIS   80.05 (-1.98%)
AMC   8.08 (-0.86%)
PFE   34.10 (+0.47%)
PYPL   57.66 (-1.54%)
NFLX   376.18 (-1.09%)
S&P 500   4,228.67 (-1.39%)
DOW   33,016.71 (-1.25%)
QQQ   355.08 (-1.71%)
AAPL   172.09 (-0.96%)
MSFT   312.84 (-2.78%)
META   300.00 (-2.22%)
GOOGL   132.92 (-0.93%)
AMZN   125.16 (-3.32%)
TSLA   248.04 (-1.41%)
NVDA   436.22 (-2.59%)
NIO   8.70 (-1.02%)
BABA   84.61 (-2.22%)
AMD   100.33 (-2.85%)
T   14.68 (+0.07%)
F   12.07 (-1.95%)
MU   68.16 (+0.29%)
CGC   0.70 (-5.10%)
GE   107.58 (-1.11%)
DIS   80.05 (-1.98%)
AMC   8.08 (-0.86%)
PFE   34.10 (+0.47%)
PYPL   57.66 (-1.54%)
NFLX   376.18 (-1.09%)
Top-Rated StocksTop-Rated
NASDAQ:RCM

R1 RCM (RCM) Stock Forecast, Price & News

$14.37
-0.58 (-3.88%)
(As of 01:27 PM ET)
Compare
Today's Range
$14.37
▼
$14.85
50-Day Range
$14.95
▼
$18.22
52-Week Range
$6.71
▼
$19.46
Volume
775,237 shs
Average Volume
2.50 million shs
Market Capitalization
$6.02 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.11
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability

R1 RCM MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.88 Rating Score
Upside/​Downside
29.5% Upside
$19.11 Price Target
Short Interest
Bearish
8.35% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.33
Upright™ Environmental Score
News Sentiment
1.31mentions of R1 RCM in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$858,500 Sold Last Quarter
Proj. Earnings Growth
233.33%
From $0.09 to $0.30 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.94 out of 5 stars

Business Services Sector

24th out of 319 stocks

Management Services Industry

2nd out of 5 stocks

See Top Rated MarketRank™ Stocks Here

RCM stock logo

About R1 RCM (NASDAQ:RCM) Stock

R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and physician groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers. The company provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. R1 RCM Inc. was founded in 2003 and is headquartered in Murray, Utah.

RCM Price History

RCM Stock News Headlines

September 26, 2023 | finance.yahoo.com
Assessing the True Worth of R1 RCM (RCM): A Comprehensive Guide to its Valuation
September 26, 2023 | finance.yahoo.com
Unraveling the Future of R1 RCM Inc (RCM): A Deep Dive into Key Metrics
October 3, 2023 | Chaikin Analytics (Ad)
Buy This Stock for AI Tidal Wave (not NVDA)
The internet boom made more millionaires than any tech  - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.
September 24, 2023 | americanbankingnews.com
R1 RCM (NASDAQ:RCM) Now Covered by Citigroup
September 24, 2023 | americanbankingnews.com
R1 RCM (NASDAQ:RCM) Rating Reiterated by Royal Bank of Canada
September 23, 2023 | americanbankingnews.com
R1 RCM Inc. (NASDAQ:RCM) Given Average Recommendation of "Moderate Buy" by Analysts
September 20, 2023 | finance.yahoo.com
R1 RCM Inc. sees growth despite trading at discount
September 18, 2023 | finance.yahoo.com
Returns On Capital Are Showing Encouraging Signs At R1 RCM (NASDAQ:RCM)
October 3, 2023 | Chaikin Analytics (Ad)
Buy This Stock for AI Tidal Wave (not NVDA)
The internet boom made more millionaires than any tech  - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.
September 12, 2023 | finance.yahoo.com
Implied Volatility Surging for R1 RCM (RCM) Stock Options
August 27, 2023 | msn.com
R1 RCM: Attractively Priced, Capital Produces $0.90/Share In Earnings, Reiterate Buy
August 20, 2023 | finance.yahoo.com
One R1 RCM Insider Raised Their Stake In The Previous Year
August 15, 2023 | msn.com
Cantor Fitzgerald Initiates Coverage of R1 RCM (RCM) with Overweight Recommendation
August 15, 2023 | markets.businessinsider.com
R1 RCM's Robust Client Base And $1.2 Trillion Potential: The Growth Forecast By Analyst
August 7, 2023 | markets.businessinsider.com
Truist Financial Sticks to Its Hold Rating for R1 RCM (RCM)
August 5, 2023 | markets.businessinsider.com
RBC Capital Reaffirms Their Buy Rating on R1 RCM (RCM)
August 4, 2023 | markets.businessinsider.com
Robert W. Baird Keeps Their Buy Rating on R1 RCM (RCM)
August 3, 2023 | msn.com
Barclays Maintains R1 RCM (RCM) Overweight Recommendation
August 2, 2023 | finance.yahoo.com
R1 RCM Inc. (RCM) Reports Break-Even Earnings for Q2
August 2, 2023 | finance.yahoo.com
Compared to Estimates, R1 RCM Inc. (RCM) Q2 Earnings: A Look at Key Metrics
August 2, 2023 | seekingalpha.com
R1 RCM Inc. 2023 Q2 - Results - Earnings Call Presentation
August 2, 2023 | finanznachrichten.de
R1 RCM Inc.: R1 RCM Reports Second Quarter 2023 Results
August 2, 2023 | finance.yahoo.com
R1 RCM Reports Second Quarter 2023 Results
August 1, 2023 | seekingalpha.com
R1 RCM Q2 2023 Earnings Preview
July 21, 2023 | msn.com
Guggenheim Reiterates R1 RCM (RCM) Buy Recommendation
July 21, 2023 | markets.businessinsider.com
6 Analysts Have This to Say About R1 RCM
July 19, 2023 | markets.businessinsider.com
Truist Financial Keeps Their Hold Rating on R1 RCM (RCM)
See More Headlines
Receive RCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for R1 RCM and its competitors with MarketBeat's FREE daily newsletter.

RCM Company Calendar

Last Earnings
2/16/2023
Today
10/03/2023
Next Earnings (Estimated)
11/14/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Management services
Sub-Industry
Health Care Services
Sector
Business Services
Current Symbol
NASDAQ:RCM
Previous Symbol
NYSE:RCM
CUSIP
00438V10
CIK
1472595
Web
www.r1rcm.com
Phone
(312) 324-7820
Fax
302-655-5049
Employees
27,800
Year Founded
2003

Price Target and Rating

Average Stock Price Forecast
$19.11
High Stock Price Forecast
$25.00
Low Stock Price Forecast
$10.00
Forecasted Upside/Downside
+27.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.88
Research Coverage
16 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($0.16)
Trailing P/E Ratio
N/A
Forward P/E Ratio
166.11
P/E Growth
N/A
Net Income
$-57,600,000.00
Net Margins
-3.09%
Pretax Margin
-2.82%
Return on Equity
-2.41%
Return on Assets
-1.30%

Debt

Debt-to-Equity Ratio
0.62
Current Ratio
1.80
Quick Ratio
1.80

Sales & Book Value

Annual Sales
$1.81 billion
Price / Sales
3.47
Cash Flow
$0.28 per share
Price / Cash Flow
53.19
Book Value
$6.53 per share
Price / Book
2.29

Miscellaneous

Outstanding Shares
418,960,000
Free Float
263,944,000
Market Cap
$6.26 billion
Optionable
Not Optionable
Beta
0.87

Social Links

12 Stocks Corporate Insiders are Abandoning Cover
12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Lee RivasMr. Lee Rivas (Age 48)
    CEO & Director
    Comp: $1.12M
  • Mr. John M. SparbyMr. John M. Sparby (Age 47)
    Pres
    Comp: $656.99k
  • Ms. Jennifer Williams (Age 46)
    Exec. VP, CFO & Treasurer
  • Mr. Richard B. Evans Jr.Mr. Richard B. Evans Jr. (Age 55)
    Sr. VP, Corp. Controller & Chief Accounting Officer
  • Mr. Atif A. Rahim
    Sr. VP of Investor Relations & Bus. Devel.
  • Mr. Corey Perman
    Exec. VP of Compliance & Risk
  • Mr. Sean Radcliffe
    Exec. VP, Gen. Counsel & Corp. Sec.
  • Ms. Kate Sanderson
    Exec. VP & Chief HR Officer
  • Mr. David Strickle
    Exec. VP of Integration
  • Mr. Kyle A. Hicok (Age 43)
    Exec. VP & Chief Commercial Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













RCM Stock - Frequently Asked Questions

Should I buy or sell R1 RCM stock right now?

16 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for R1 RCM in the last year. There are currently 2 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" RCM shares.
View RCM analyst ratings or view top-rated stocks.

What is R1 RCM's stock price forecast for 2023?

16 Wall Street analysts have issued twelve-month target prices for R1 RCM's stock. Their RCM share price forecasts range from $10.00 to $25.00. On average, they predict the company's stock price to reach $19.11 in the next year. This suggests a possible upside of 27.8% from the stock's current price.
View analysts price targets for RCM or view top-rated stocks among Wall Street analysts.

How have RCM shares performed in 2023?

R1 RCM's stock was trading at $10.95 at the beginning of 2023. Since then, RCM stock has increased by 36.5% and is now trading at $14.95.
View the best growth stocks for 2023 here.

When is R1 RCM's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our RCM earnings forecast.

How were R1 RCM's earnings last quarter?

R1 RCM Inc. (NASDAQ:RCM) issued its quarterly earnings results on Thursday, February, 16th. The healthcare provider reported ($0.09) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.03) by $0.06. The healthcare provider earned $532.80 million during the quarter, compared to the consensus estimate of $519.28 million. R1 RCM had a negative net margin of 3.09% and a negative trailing twelve-month return on equity of 2.41%. The company's revenue was up 33.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.11 EPS.

What ETFs hold R1 RCM's stock?

ETFs with the largest weight of R1 RCM (NASDAQ:RCM) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Thrivent Small-Mid Cap ESG ETF (TSME), Fidelity Digital Health ETF (FDHT), SPDR S&P Health Care Services ETF (XHS) and iShares U.S. Healthcare Providers ETF (IHF).Invesco NASDAQ Next Gen 100 ETF (QQQJ).

What guidance has R1 RCM issued on next quarter's earnings?

R1 RCM updated its FY 2023 earnings guidance on Wednesday, August, 2nd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $2.25 billion-$2.27 billion, compared to the consensus revenue estimate of $2.31 billion.

What is Joseph Flanagan's approval rating as R1 RCM's CEO?

253 employees have rated R1 RCM Chief Executive Officer Joseph Flanagan on Glassdoor.com. Joseph Flanagan has an approval rating of 70% among the company's employees.

What other stocks do shareholders of R1 RCM own?

Based on aggregate information from My MarketBeat watchlists, some companies that other R1 RCM investors own include NVIDIA (NVDA), JD.com (JD), Baozun (BZUN), Inseego (INSG), BioXcel Therapeutics (BTAI), Marvell Technology (MRVL), Akoustis Technologies (AKTS), Alibaba Group (BABA), Bilibili (BILI) and Model N (MODN).

What is R1 RCM's stock symbol?

R1 RCM trades on the NASDAQ under the ticker symbol "RCM."

How do I buy shares of R1 RCM?

Shares of RCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is R1 RCM's stock price today?

One share of RCM stock can currently be purchased for approximately $14.95.

How much money does R1 RCM make?

R1 RCM (NASDAQ:RCM) has a market capitalization of $6.26 billion and generates $1.81 billion in revenue each year. The healthcare provider earns $-57,600,000.00 in net income (profit) each year or ($0.16) on an earnings per share basis.

How many employees does R1 RCM have?

The company employs 27,800 workers across the globe.

Does R1 RCM have any subsidiaries?
The following companies are subsidiares of R1 RCM: Accretive Health Mauritius Inc., Cerner RevWorks, Clearsight Intermediate Holdings Inc., Cloudmed, Flare Capital Partners Investment Company, Intermedix, Intermedix ARM LLC, Intermedix Corporation, Intermedix Holdings Inc., Intermedix Lietuva UAB, Intermedix Midco Inc., Intermedix Office Based LLC, Intermedix Staffing Inc., Medical Consultants Inc., Practice Support Resources LLC, Project Links Parent Inc., Project Roadrunner Merger Sub Inc., Project Roadrunner Parent Inc., R1 RCM Global Private Limited, R1 RCM India Private Limited, Rover16 Inc., SCHEDULING.COM INC., SCI Solutions, Tonic Health LLC, VisitPay, cGate Health Inc., and iVinci Partners LLC.
Read More
How can I contact R1 RCM?

R1 RCM's mailing address is 401 NORTH MICHIGAN AVENUE SUITE 2700, CHICAGO IL, 60611. The official website for the company is www.r1rcm.com. The healthcare provider can be reached via phone at (312) 324-7820, via email at arahim@r1rcm.com, or via fax at 302-655-5049.

This page (NASDAQ:RCM) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -